{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:42:12Z","timestamp":1778798532781,"version":"3.51.4"},"reference-count":43,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":91,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","doi-asserted-by":"crossref","award":["R21AA019994"],"award-info":[{"award-number":["R21AA019994"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","doi-asserted-by":"crossref","award":["5T32AA007459-28"],"award-info":[{"award-number":["5T32AA007459-28"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIAAA Division of Intramural Clinical and Biological Research"},{"name":"National Institute on Drug Abuse (NIDA) Intramural Research Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Addiction Biology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1111\/adb.12275","type":"journal-article","created":{"date-parts":[[2015,6,3]],"date-time":"2015-06-03T01:57:25Z","timestamp":1433296645000},"page":"904-914","source":"Crossref","is-referenced-by-count":61,"title":["Role of the \u03b1<sub>1<\/sub>blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial"],"prefix":"10.1111","volume":"21","author":[{"given":"George A.","family":"Kenna","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Human Behavior; Center for Alcohol and Addiction Studies; Brown University; Providence RI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina L.","family":"Haass-Koffler","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Social Sciences; Center for Alcohol and Addiction Studies; Brown University; Providence RI USA"},{"name":"Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology; National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse; National Institutes of Health; Bethesda MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Zywiak","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Human Behavior; Center for Alcohol and Addiction Studies; Brown University; Providence RI USA"},{"name":"Decision Sciences Institute; PIRE; Pawtucket RI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Psychology; University of Nebraska-Lincoln; Lincoln NE USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Brickley","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Social Sciences; Center for Alcohol and Addiction Studies; Brown University; Providence RI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Swift","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Human Behavior; Center for Alcohol and Addiction Studies; Brown University; Providence RI USA"},{"name":"Veterans Affairs Medical Center; Providence RI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Leggio","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Social Sciences; Center for Alcohol and Addiction Studies; Brown University; Providence RI USA"},{"name":"Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology; National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse; National Institutes of Health; Bethesda MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,6,2]]},"reference":[{"key":"10.1111\/adb.12275-BIB0001|adb12275-cit-0001","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0090-4295(01)01302-4","article-title":"Terazosin, doxazosin, and prazosin: current clinical experience","volume":"58","author":"Akduman","year":"2001","journal-title":"Urology"},{"key":"10.1111\/adb.12275-BIB0002|adb12275-cit-0002","first-page":"65","article-title":"Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine-beta-hydroxylase inhibition","volume":"230","author":"Amit","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1111\/adb.12275-BIB0003|adb12275-cit-0003","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1530-0277.1995.tb01475.x","article-title":"The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior","volume":"19","author":"Anton","year":"1995","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/adb.12275-BIB0004|adb12275-cit-0004","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/adb.12275-BIB0005|adb12275-cit-0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.15288\/jsad.2011.72.135","article-title":"Does family history of alcoholism moderate naltrexone's effects on alcohol use?","volume":"72","author":"Capone","year":"2011","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1111\/adb.12275-BIB0006|adb12275-cit-0006","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.ALC.0000125345.19665.09","article-title":"Acoustic startle reactivity during acute alcohol withdrawal in rats that differ in genetic predisposition toward alcohol drinking: effect of stimulus characteristics","volume":"28","author":"Chester","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/adb.12275-BIB0007|adb12275-cit-0007","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J Health Soc Behav"},{"key":"10.1111\/adb.12275-BIB0008|adb12275-cit-0008","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/JCP.0b013e3181c827ae","article-title":"Doxazosin treatment for posttraumatic stress disorder","volume":"30","author":"De Jong","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/adb.12275-BIB0009|adb12275-cit-0009","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1530-0277.1996.tb01142.x","article-title":"Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer","volume":"20","author":"Del Boca","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/adb.12275-BIB0010|adb12275-cit-0010","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1530-0277.1997.tb04450.x","article-title":"Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence","volume":"21","author":"Ehrenreich","year":"1997","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/adb.12275-BIB0011|adb12275-cit-0011","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1530-0277.2010.01290.x","article-title":"Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials","volume":"34","author":"Falk","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/adb.12275-BIB0012|adb12275-cit-0012","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1530-0277.2011.01628.x","article-title":"Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings","volume":"36","author":"Fox","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/adb.12275-BIB0013|adb12275-cit-0013","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(89)90032-0","article-title":"Demonstration of alpha 1A- and alpha 1B-adrenoceptor binding sites in human brain tissue","volume":"169","author":"Gross","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/adb.12275-BIB0014|adb12275-cit-0014","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/alcalc\/agt134","article-title":"Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials","volume":"48","author":"Gurvich","year":"2013","journal-title":"Alcohol Alcohol"},{"key":"10.1111\/adb.12275-BIB0015|adb12275-cit-0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"10.1111\/adb.12275-BIB0016|adb12275-cit-0016","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrn3110","article-title":"Pharmacogenetic approaches to the treatment of alcohol addiction","volume":"12","author":"Heilig","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1111\/adb.12275-BIB0017|adb12275-cit-0017","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.drugalcdep.2012.08.007","article-title":"Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement","volume":"128","author":"Herron","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/adb.12275-BIB0018|adb12275-cit-0018","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.pcan.4500220","article-title":"Morning vs evening dosing with doxazosin in benign prostatic hyperplasia: efficacy and safety","volume":"1","author":"Kirby","year":"1998","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1111\/adb.12275-BIB0019|adb12275-cit-0019","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2008.06.012","article-title":"A role for brain stress systems in addiction","volume":"59","author":"Koob","year":"2008","journal-title":"Neuron"},{"key":"10.1111\/adb.12275-BIB0020|adb12275-cit-0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s002130050285","article-title":"Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP)","volume":"131","author":"Krystal","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/adb.12275-BIB0021|adb12275-cit-0021","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00213-011-2178-7","article-title":"Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats","volume":"218","author":"Le","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/adb.12275-BIB0022|adb12275-cit-0022","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11065-008-9080-z","article-title":"Typologies of alcohol dependence. From Jellinek to genetics and beyond","volume":"19","author":"Leggio","year":"2009","journal-title":"Neuropsychol Rev"},{"key":"10.1111\/adb.12275-BIB0023|adb12275-cit-0023","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1017\/S1461145714000790","article-title":"Topiramate for alcoholism treatment: novel pharmacogenetic evidence for the journey to personalized medicine?","volume":"17","author":"Leggio","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1111\/adb.12275-BIB0024|adb12275-cit-0024","first-page":"343","article-title":"SAFTEE: a technique for the systematic assessment of side effects in clinical trials","volume":"22","author":"Levine","year":"1986","journal-title":"Psychopharmacol Bull"},{"key":"10.1111\/adb.12275-BIB0025|adb12275-cit-0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0376-8716(79)90040-1","article-title":"Progress toward a voluntary oral consumption model of alcoholism","volume":"4","author":"Li","year":"1979","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/adb.12275-BIB0026|adb12275-cit-0026","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jama.299.3.296","article-title":"Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension","volume":"299","author":"Lynch","year":"2008","journal-title":"JAMA"},{"key":"10.1111\/adb.12275-BIB0027|adb12275-cit-0027","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0376-8716(85)90030-4","article-title":"Reliability of a family tree questionnaire for assessing family history of alcohol problems","volume":"15","author":"Mann","year":"1985","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/adb.12275-BIB0028|adb12275-cit-0028","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/gcen.1995.1028","article-title":"Preliminary evidence of a synergistic alpha 1- and beta 1-adrenoceptor regulation of rat pineal hydroxyindole-O-methyltransferase","volume":"97","author":"McLeod","year":"1995","journal-title":"Gen Comp Endocrinol"},{"key":"10.1111\/adb.12275-BIB0029|adb12275-cit-0029","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.alcohol.2009.07.002","article-title":"Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol-preferring Sprague-Dawley rats","volume":"43","author":"Moorman","year":"2009","journal-title":"Alcohol"},{"key":"10.1111\/adb.12275-BIB0030|adb12275-cit-0030","doi-asserted-by":"crossref","first-page":"e30854","DOI":"10.1371\/journal.pone.0030854","article-title":"Noradrenergic alpha(1) receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial","volume":"7","author":"Newton","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/adb.12275-BIB0031|adb12275-cit-0031","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1530-0277.2012.01884.x","article-title":"The alpha1-adrenergic receptor antagonist, doxazosin, reduces alcohol drinking in alcohol-preferring (P) rats","volume":"37","author":"O'Neil","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/adb.12275-BIB0032|adb12275-cit-0032","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/10550490490459898","article-title":"Differences in peripheral noradrenergic function among actively drinking and abstinent alcohol-dependent individuals","volume":"13","author":"Patkar","year":"2004","journal-title":"Am J Addict"},{"key":"10.1111\/adb.12275-BIB0033|adb12275-cit-0033","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00005053-197910000-00004","article-title":"Profile of Mood States: the factors and their physiological correlates","volume":"167","author":"Pollock","year":"1979","journal-title":"J Nerv Ment Dis"},{"key":"10.1111\/adb.12275-BIB0034|adb12275-cit-0034","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1530-0277.2008.00829.x","article-title":"The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats","volume":"33","author":"Rasmussen","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/adb.12275-BIB0035|adb12275-cit-0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1037\/a0029315","article-title":"When can categorical variables be treated as continuous? A comparison of robust continuous and categorical SEM estimation methods under suboptimal conditions","volume":"17","author":"Rhemtulla","year":"2012","journal-title":"Psychol Methods"},{"key":"10.1111\/adb.12275-BIB0036|adb12275-cit-0036","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1037\/1064-1297.15.3.272","article-title":"Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics","volume":"15","author":"Rohsenow","year":"2007","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1111\/adb.12275-BIB0037|adb12275-cit-0037","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2012.11.021","article-title":"The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: a pilot study","volume":"131","author":"Shorter","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/adb.12275-BIB0038|adb12275-cit-0038","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1530-0277.2008.00807.x","article-title":"A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence","volume":"33","author":"Simpson","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/adb.12275-BIB0039|adb12275-cit-0039","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1037\/0021-843X.91.3.199","article-title":"Alcohol dependence syndrome: measurement and validation","volume":"91","author":"Skinner","year":"1982","journal-title":"J Abnorm Psychol"},{"key":"10.1111\/adb.12275-BIB0040|adb12275-cit-0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1360-0443.1988.tb00485.x","article-title":"Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations","volume":"83","author":"Sobell","year":"1988","journal-title":"Br J Addict"},{"key":"10.1111\/adb.12275-BIB0041|adb12275-cit-0041","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1523\/JNEUROSCI.14-11-06481.1994","article-title":"The mechanism of noradrenergic alpha 1 excitatory modulation of pontine reticular formation neurons","volume":"14","author":"Stevens","year":"1994","journal-title":"J Neurosci"},{"key":"10.1111\/adb.12275-BIB0042|adb12275-cit-0042","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0376-8716(86)90098-0","article-title":"Suppression of ethanol tolerance and dependence in rats treated with DSP-4, a noradrenergic neurotoxin","volume":"18","author":"Trzaskowska","year":"1986","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/adb.12275-BIB0043|adb12275-cit-0043","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.alcohol.2007.12.002","article-title":"alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol","volume":"42","author":"Walker","year":"2008","journal-title":"Alcohol"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadb.12275","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/adb.12275\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T10:53:13Z","timestamp":1625309593000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/adb.12275"}},"subtitle":["Doxazosin and alcoholism"],"short-title":[],"issued":{"date-parts":[[2015,6,2]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"URL":"https:\/\/doi.org\/10.1111\/adb.12275","archive":["Portico"],"relation":{},"ISSN":["1355-6215"],"issn-type":[{"value":"1355-6215","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,2]]}}}